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Sun Protection, Vitamin D Deﬁciency, and Management of
Cutaneous Oncology in Organ Transplant Recipients (OTR)
To the Editor:
We have read with great interest the excellent article of
Carucci (2004) who has carried out a comprehensive review
of epidemiology, pathogenesis, and clinical outcome of skin
cancer in organ transplant recipients (OTR) and has given
recommendations for its medical management. We would
like to add to this discussion an important topic that has not
been addressed by John A. Carucci, but that we dermatol-
ogists must be aware of: the fact that strict sun protection
may lead in OTR to the severe health risk of vitamin D de-
ficiency. We know that OTR may develop 25-hydroxyvitamin
D deficiency (Segal et al, 2001), likely at least in part due to
lack of sun exposure. But an epidemiologic association be-
tween vitamin D deficiency and a broad variety of severe
health problems including various types of malignancies
(e.g. colon-, prostate-, and breast cancer) has now been
reported convincingly (Garland et al, 1989; Grant, 2002). It is
now evident that a broad variety of tissues including skin,
prostate, colon, and breast express the enzyme (25-hydro-
xyvitamin D-1a-hydroxylase) to convert 25-hydroxyvitamin
D to its active form, 1,25-dihydroxyvitamin D (Schwartz
et al, 1998; Tangpricha et al, 2001). 1,25-dihydroxyvitamin D
is now not exclusively considered as a calciotropic hormone
but also as a locally produced regulator of different cellular
functions including cellular growth (Schwartz et al, 1998;
Tangpricha et al, 2001). As John Carucci points out, regular
dermatological follow-up must be provided for OTR. In this
context, we would like to strengthen the fact that it is of high
importance to detect and to treat 25-hydroxyvitamin D de-
ficiency in OTR. Recommendations for the oral treatment of
vitamin D deficiency have been reported previously (Ma-
labanan et al, 1998; Vieth, 1999). A single dose of 50,000 IU
vitamin D once a week for 8 wk is efficient and safe. Another
means of guaranteeing vitamin D sufficiency is to give
50,000 IU of vitamin D once a month. We would like to
accentuate the fact that careful monitoring of vitamin D
status and oral substitution in case of vitamin D deficiency
is of high importance for OTR, as we have recommended
previously (Reichrath, 2003, 2004). This will protect OTR
sufficiently against the serious health problems of 25-hy-
droxyvitamin D deficiency without further increasing their
risk of developing squamous cell carcinoma of the skin or
other types of UV-induced skin cancer.
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Variation in Skin Thickness May Explain Some of the
Within-Person Variation in Ultraviolet Radiation-Induced
Erythema at Different Body Sites
To the Editor:
We recently reported to this journal results showing a strik-
ing variation in erythemal sensitivity to ultraviolet radiation
(UVR) at different body sites (Waterston et al, 2004). Briefly,
in a UK population, variation within persons was as large as
variation between persons. We also noted a smaller varia-
tion in inflammatory response to anthralin. In our paper, we
failed to explain this variation in terms of resting vascular
flow but showed a correlation with site-specific skin pig-
mentation.
Subsequently, we have become aware of an additional
factor that may also explain our results. Although it has
been shown that between-person UVR-induced erythema
shows a poor correlation with stratum corneum and
epidermal thickness (Lock-Anderson et al, 1997), plotting
of erythemal sensitivity against stratum corneum or total
epidermis thickness shows a suggestive pattern (Figs 1
and 2).
Correlation does not imply causality but we suggest that
such variation in stratum corneum or epidermis is a plau-
sible determinant of the biological dose of UVR received by
the lower epidermis, and hence of inflammatory response.
This explanation does not exclude a role for site-specific
variation in pigmentation.
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Figure 1
Relation between stratum corneum thickness (mm) and reflectance
measurements of erythema at 24 h following exposure to 300 mJ per
cm2 (8.2 SED) of ultraviolet B for four body sites. Stratum corneum
thickness data are taken from Holbrook and Odland (1974).
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Figure2
Relation between epidermal thickness (mm) and reflectance measure-
ments of erythema at 24 h following exposure to 300 mJ per cm2 (8.2
SED) of ultraviolet B for eight body sites. Epidermal thickness data are
taken from Whitton and Everall (1973). Where thickness data do not
specify the exact area, the mean erythema value of two sites (such as
the inner and outer forearm, front and back thigh, etc.) is plotted.
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